Tang Liu, Geng Huiliang, Zhang Lei, Wang Xinyi, Fei Mengdan, Yang Boyuan, Sun Haijie, Zhang Zhongli
Analytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, China.
ACS Pharmacol Transl Sci. 2024 Jul 18;7(8):2476-2483. doi: 10.1021/acsptsci.4c00296. eCollection 2024 Aug 9.
The oxidation of the complementarity-determining region (CDR) in monoclonal antibodies (mAbs) is a critical quality attribute that can affect the clinical efficacy and safety of recombinant mAb therapeutics. In this study, a robust hydrophobic interaction chromatography (HIC) method was developed to quantify and characterize CDR oxidation variants in mAb-A by using a Proteomix Butyl-NP5 column. The HIC analysis revealed oxidation variants that eluted earlier than the main species with weaker hydrophobicity. It was found that Met in the CDR was more susceptible to oxidation. Additionally, it was noted that the oxidation of Met on a single heavy chain resulted in elution at a distinct position compared to the oxidation on two heavy chains. This observation led to the fractionation and enrichment of the oxidized variants for further evaluation of their biofunction. The study also demonstrated that the oxidation of Met did not impact the antigen-binding capacity but significantly reduced the PD-1/PD-L1 blockade activity of mAb-A. The HIC method, which was employed to quantify CDR oxidation, underwent validation and was subsequently utilized for stability studies as well as for assessing the similarity between mAb-A and its reference product.
单克隆抗体(mAb)中互补决定区(CDR)的氧化是一个关键的质量属性,会影响重组单克隆抗体治疗药物的临床疗效和安全性。在本研究中,开发了一种稳健的疏水相互作用色谱(HIC)方法,通过使用Proteomix Butyl-NP5柱来定量和表征mAb-A中的CDR氧化变体。HIC分析揭示了比主要物种洗脱更早且疏水性较弱的氧化变体。发现CDR中的甲硫氨酸(Met)更容易被氧化。此外,还注意到单条重链上Met的氧化与两条重链上的氧化相比,会在不同位置洗脱。这一观察结果使得氧化变体得以分馏和富集,以便进一步评估其生物功能。该研究还表明,Met的氧化不影响抗原结合能力,但显著降低了mAb-A的PD-1/PD-L1阻断活性。用于定量CDR氧化的HIC方法经过了验证,随后被用于稳定性研究以及评估mAb-A与其参比产品之间的相似性。